Finance

Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
541,25 INR
-0,41%
(-2,25) 1D
13-окт., 11:38:17 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
545,00 INR
High
548,10 INR
Low
538,05 INR
Mkt. cap
10,84 млд
Avg. vol.
32,76 миң
Volume
7,42 миң
Dividend
0,33%
Quarterly dividend
0,45 INR
Ex-dividend date
2026-ж., 11-сен.
P/E ratio
11,24
52-wk high
770,00 INR
52-wk low
440,00 INR
EPS
48,16 INR
Shares outstanding
20,00 млн
No. of employees
1 миң
Open
545,00 INR
High
548,10 INR
Low
538,05 INR
Mkt. cap
10,84 млд
Avg. vol.
32,76 миң
Volume
7,42 миң
Dividend
0,33%
Quarterly dividend
0,45 INR
Ex-dividend date
2026-ж., 11-сен.
P/E ratio
11,24
52-wk high
770,00 INR
52-wk low
440,00 INR
EPS
48,16 INR
Shares outstanding
20,00 млн
No. of employees
1 миң
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
21 мүнөт мурун
Stock Market: Will S&P 500 Open Up or Down Today?
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
1 саат мурун
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City
Seeking Alpha
Seeking Alpha
·
19 мүнөт мурун
Our October Perspective
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1,35 миң
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 13-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,77 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,63 млд
1,66 млд
1,87 млд
1,77 млд
Cost of goods sold
767,46 млн
759,60 млн
967,33 млн
851,43 млн
Cost of revenue
767,46 млн
759,60 млн
967,33 млн
851,43 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303,56 млн
306,18 млн
389,12 млн
333,10 млн
Operating expense
648,09 млн
704,87 млн
684,68 млн
685,91 млн
Total operating expenses
1,42 млд
1,46 млд
1,65 млд
1,54 млд
Operating income
218,09 млн
198,75 млн
220,76 млн
235,48 млн
Other non operating income
72,32 млн
151,46 млн
-379,32 млн
242,65 млн
EBT including unusual items
288,11 млн
347,22 млн
167,03 млн
475,54 млн
EBT excluding unusual items
288,11 млн
347,22 млн
146,26 млн
475,54 млн
Income tax expense
88,27 млн
61,22 млн
50,68 млн
113,19 млн
Effective tax rate
30,64%
17,63%
30,34%
23,80%
Other operating expenses
308,34 млн
361,49 млн
258,73 млн
313,96 млн
Net income
199,84 млн
286,00 млн
116,35 млн
362,34 млн
Net profit margin
12,23%
17,20%
6,21%
20,44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
82,21 млн
-
Interest expense
-2,31 млн
-2,98 млн
-
-2,59 млн
Net interest expenses
-2,31 млн
-2,98 млн
82,21 млн
-2,59 млн
Depreciation and amortization charges
36,19 млн
37,21 млн
36,83 млн
38,84 млн
EBITDA
253,58 млн
230,69 млн
256,62 млн
271,73 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору